These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8902438)

  • 1. Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS).
    Schaefer C; Amoura-Elefant E; Vial T; Ornoy A; Garbis H; Robert E; Rodriguez-Pinilla E; Pexieder T; Prapas N; Merlob P
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):83-9. PubMed ID: 8902438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.
    Diav-Citrin O; Shechtman S; Ornoy S; Arnon J; Schaefer C; Garbis H; Clementi M; Ornoy A
    J Clin Psychiatry; 2005 Mar; 66(3):317-22. PubMed ID: 15766297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
    Schaefer C; Hannemann D; Meister R
    Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
    Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
    Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy.
    De Santis M; Di Gianantonio E; Cesari E; Ambrosini G; Straface G; Clementi M
    Drug Saf; 2009; 32(3):239-44. PubMed ID: 19338381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS).
    McElhatton PR; Garbis HM; Eléfant E; Vial T; Bellemin B; Mastroiacovo P; Arnon J; Rodríguez-Pinilla E; Schaefer C; Pexieder T; Merlob P; Dal Verme S
    Reprod Toxicol; 1996; 10(4):285-94. PubMed ID: 8829251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
    Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
    BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical approval for multicenter cohort studies on drug exposure during pregnancy: A survey among members of the European Network of Teratology Information Services (ENTIS).
    Winterfeld U; Weber-Schöndorfer C; Schaefer C; von Elm E; Buclin T
    Reprod Toxicol; 2018 Sep; 80():68-72. PubMed ID: 29913205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry.
    Cardonick E; Usmani A; Ghaffar S
    Am J Clin Oncol; 2010 Jun; 33(3):221-8. PubMed ID: 19745695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome after in utero exposure to colchicine.
    Diav-Citrin O; Shechtman S; Schwartz V; Avgil-Tsadok M; Finkel-Pekarsky V; Wajnberg R; Arnon J; Berkovitch M; Ornoy A
    Am J Obstet Gynecol; 2010 Aug; 203(2):144.e1-6. PubMed ID: 20579964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.
    Coppola D; Russo LJ; Kwarta RF; Varughese R; Schmider J
    Drug Saf; 2007; 30(3):247-64. PubMed ID: 17343431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
    Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
    J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcomes following exposure to abatacept during pregnancy.
    Kumar M; Ray L; Vemuri S; Simon TA
    Semin Arthritis Rheum; 2015 Dec; 45(3):351-6. PubMed ID: 26210783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
    Schaefer C; Meister R; Weber-Schoendorfer C
    Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
    Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
    Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the teratogenic and fetotoxic effects of large doses of chlordiazepoxide used for self-poisoning by 35 pregnant women.
    Gidai J; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):41-51. PubMed ID: 18818180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome after first trimester exposure to ionizing radiations.
    Guilbaud L; Beghin D; Dhombres F; Blondiaux E; Friszer S; Ducou Le Pointe H; Éléfant E; Jouannic JM
    Eur J Obstet Gynecol Reprod Biol; 2019 Jan; 232():18-21. PubMed ID: 30453167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study.
    Loebstein R; Addis A; Ho E; Andreou R; Sage S; Donnenfeld AE; Schick B; Bonati M; Moretti M; Lalkin A; Pastuszak A; Koren G
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1336-9. PubMed ID: 9624471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy.
    Namazy J; Cabana MD; Scheuerle AE; Thorp JM; Chen H; Carrigan G; Wang Y; Veith J; Andrews EB
    J Allergy Clin Immunol; 2015 Feb; 135(2):407-12. PubMed ID: 25441639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.
    Magee LA; Inocencion G; Kamboj L; Rosetti F; Koren G
    Dig Dis Sci; 1996 Jun; 41(6):1145-9. PubMed ID: 8654145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.